Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Find out more

Home › Resources › Videos and webinars › Reducing Compound Attrition by Predicting Renal Tubular Toxicity with in vitro PTEC Models

Reducing Compound Attrition by Predicting Renal Tubular Toxicity with in vitro PTEC Models

In this webinar, Dr Piyush Bajaj presents on “Reducing Compound Attrition by Predicting Renal Tubular Toxicity with in vitro PTEC Models”.

Date: Thursday 24th September 2020

Published

1st September, 2020

Published by

Dr Piyush Bajaj & Dr Colin Brown

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.

Book a Call